Correlation Between Medipharm Labs and Bionoid Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Bionoid Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Bionoid Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and Bionoid Pharma, you can compare the effects of market volatilities on Medipharm Labs and Bionoid Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Bionoid Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Bionoid Pharma.

Diversification Opportunities for Medipharm Labs and Bionoid Pharma

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Medipharm and Bionoid is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Bionoid Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bionoid Pharma and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Bionoid Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bionoid Pharma has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Bionoid Pharma go up and down completely randomly.

Pair Corralation between Medipharm Labs and Bionoid Pharma

Assuming the 90 days horizon Medipharm Labs is expected to generate 26.09 times less return on investment than Bionoid Pharma. But when comparing it to its historical volatility, Medipharm Labs Corp is 4.5 times less risky than Bionoid Pharma. It trades about 0.01 of its potential returns per unit of risk. Bionoid Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  45.00  in Bionoid Pharma on August 26, 2024 and sell it today you would lose (25.00) from holding Bionoid Pharma or give up 55.56% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medipharm Labs Corp  vs.  Bionoid Pharma

 Performance 
       Timeline  
Medipharm Labs Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward indicators, Medipharm Labs is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Bionoid Pharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bionoid Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively conflicting basic indicators, Bionoid Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Medipharm Labs and Bionoid Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medipharm Labs and Bionoid Pharma

The main advantage of trading using opposite Medipharm Labs and Bionoid Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Bionoid Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bionoid Pharma will offset losses from the drop in Bionoid Pharma's long position.
The idea behind Medipharm Labs Corp and Bionoid Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities